UPC Analytics
DEEN
Übersicht · Eingereicht: —

ACT_14945/2024

ANALYTE SENSOR DEVICES, CONNECTIONS, AND METHODS

Einstweilige MaßnahmenEinstweilige MaßnahmenThe Hague LDApplication for provisional measures—
ÜbersichtEntscheidungenBegründungZitateDokumenteZeitverlauf
Parteien

Kläger

Vertreter: Eelco Bergsma

Beklagte

  • Sibio Technology Limited
  • Umedwings Netherlands B.V.
Vertreter: Thomas Gniadek
Richter
  • Edger BrinkmanPresiding judge, judge-rapporteur
  • Petri RinkinenLegally qualified judge
  • Margot KokkeLegally qualified judge
  • Renaud FulconisTechnically qualified judge
Patente
  • EP 3 831 283
CPC-Codes: A61B5/1451, H04L67/12, A61B5/15087, A61B5/145, A61B5/150022, A61B5/150335, A61B5/14503, A61B5/6849, A61B5/0004, A61B5/14532, A61B5/150503, A61B5/150877…

Sektor: Pharmaceutical & Medical

Ausgang
PI abgelehnt
Eingereicht: —
Erste Entscheidung: 19. Juni 2024
Sprache: —

Application for a preliminary injunction by Abbott Diabetes Care Inc. against Sibio Technology Limited and Umedwings Netherlands B.V. concerning EP 3 831 283 (wearable glucose monitoring device) was denied by The Hague Local Division. The court found it more likely than not that claim 1 of the patent would be held invalid for added matter (the claimed feature of a connector support being received through a distal-facing opening into a recess was not directly and unambiguously derivable from the application as filed). As a result, Abbott must bear defendants' costs. Value of the action set at EUR 4,000,000.